After several years of relatively little enforcement, FDA has recently been flexing its muscles in the promotion area. The Office of Prescription Drug Promotion (OPDP) in particular has issued several notable warning and untitled letters in the past year, representing an increased volume in enforcement and increased scrutiny of efficacy claims. This includes more rigorous […]
Join Sidley, ISS AG, and Swiss Medtech in Biel for an afternoon of practical tips and interactive discussions on current issues, including: ESG and its development in the EU Seizing the opportunities of Artificial Intelligence Health data and clinical trials 2:00 p.m. – 6:30 p.m. CET Followed by a networking drinks reception RSVP here. Industry speakers, […]
Live Oak Workshops, in collaboration with Sidley Austin, are designed to equip you with the knowledge and critical thinking strategies that lead to success in the advancement of your GXP career. As worldwide regulatory expectations in the world of data integrity and data governance change, our workshops prepare you with the skills necessary to interpret […]
Deal and investment activity remains critical to the success of life sciences and healthcare innovation. RSVP Here Sidley once again brings together senior pharma, biotech, healthcare, private equity, and venture capital executives to share their perspectives on critical issues, trends, and opportunities. Join Sidley and industry leaders from across the globe, including from AstraZeneca, BioCentury, Compass […]
Join us in Basel for our next Women’s Life Sciences Network event. The panel will discuss key considerations related to authority expectations as well as challenges, and potential strategies for EU regulatory and competition law compliance for combination therapies. RSVP here. Speakers are: Dr. Sandra Zaugg Kunz, Head Regulatory Assessment Deputy Head of Medicinal Product Authorisation […]
Join us in Basel, where Sidley and thought leaders will be discussing the FDA and Swissmedic Mutual Recognition Agreement on Good Manufacturing Practices for pharmaceutical products. This agreement aims to streamline regulatory processes and enhance cooperation between the two countries by recognizing each other’s GMP inspections, thereby reducing the need for duplicative inspections. RSVP here. We […]
Please join Sidley’s Global Life Sciences team to lean into key early-stage and emerging growth regulatory issues, and how to tackle them. If have questions or are interested in attending, please contact laevents@sidley.com. Sessions will focus on: All phases of clinical research and development Press releases and disclosures Regulatory wisdom from experienced emerging growth General Counsels […]
Join Sidley’s Life Sciences team for an afternoon of thought-provoking and engaging discussions touching on the latest trends and hot topics including the new administration, new technologies, the investment landscape, and more. For more information, contact bosevents@sidley.com. This year's fifth annual event will be held in the stunning Institute of Contemporary Art/Boston lobby, followed by a […]
Join us in Brussels for our next Women’s Life Sciences Network event on the occasion of the EU Pharmaceutical Law Forum. The event will feature a moderated discussion with Rainer Becker, Director, DG SANTE, European Commission, on topical issues of pharmaceutical legislation and policy. Stay tuned for a formal invitation and additional speaker announcements coming soon.
The Swiss MedTech industry stands at a critical crossroads: navigating rapid regulatory evolution, geopolitical shifts, and emerging technologies. For more information, please contact Geneva Events. Join us in Bern for an interactive afternoon featuring regulators, industry leaders, legal professionals, and scientific advisors who will share practical insights, best practices, and strategic foresight. Key highlights on the […]